» Articles » PMID: 16508002

Regulation and Role of Raf-1/B-Raf Heterodimerization

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2006 Mar 2
PMID 16508002
Citations 192
Authors
Affiliations
Soon will be listed here.
Abstract

The Ras-Raf-MEK-extracellular signal-regulated kinase (ERK) pathway participates in the control of many fundamental cellular processes including proliferation, survival, and differentiation. The pathway is deregulated in up to 30% of human cancers, often due to mutations in Ras and the B-Raf isoform. Raf-1 and B-Raf can form heterodimers, and this may be important for cellular transformation. Here, we have analyzed the biochemical and biological properties of Raf-1/B-Raf heterodimers. Isolated Raf-1/B-Raf heterodimers possessed a highly increased kinase activity compared to the respective homodimers or monomers. Heterodimers between wild-type Raf-1 and B-Raf mutants with low or no kinase activity still displayed elevated kinase activity, as did heterodimers between wild-type B-Raf and kinase-negative Raf-1. In contrast, heterodimers containing both kinase-negative Raf-1 and kinase-negative B-Raf were completely inactive, suggesting that the kinase activity of the heterodimer specifically originates from Raf and that either kinase-competent Raf isoform is sufficient to confer high catalytic activity to the heterodimer. In cell lines, Raf-1/B-Raf heterodimers were found at low levels. Heterodimerization was enhanced by 14-3-3 proteins and by mitogens independently of ERK. However, ERK-induced phosphorylation of B-Raf on T753 promoted the disassembly of Raf heterodimers, and the mutation of T753 prolonged growth factor-induced heterodimerization. The B-Raf T753A mutant enhanced differentiation of PC12 cells, which was previously shown to be dependent on sustained ERK signaling. Fine mapping of the interaction sites by peptide arrays suggested a complex mode of interaction involving multiple contact sites with a main Raf-1 binding site in B-Raf encompassing T753. In summary, our data suggest that Raf-1/B-Raf heterodimerization occurs as part of the physiological activation process and that the heterodimer has distinct biochemical properties that may be important for the regulation of some biological processes.

Citing Articles

Histone deacetylases in the regulation of cell death and survival mechanisms in resistant BRAF-mutant cancers.

Biersack B, Nitzsche B, Hopfner M Cancer Drug Resist. 2025; 8:6.

PMID: 39935431 PMC: 11810460. DOI: 10.20517/cdr.2024.125.


Discovery of novel naphthalene-based diarylamides as pan-Raf kinase inhibitors with promising anti-melanoma activity: rational design, synthesis, in vitro and in silico screening.

Elkamhawy A, Ammar U, Kim M, Gul A, Park T, Lee K Arch Pharm Res. 2025; 48(2):150-165.

PMID: 39920399 PMC: 11861015. DOI: 10.1007/s12272-025-01533-5.


Targeted protein degradation: advances in drug discovery and clinical practice.

Zhong G, Chang X, Xie W, Zhou X Signal Transduct Target Ther. 2024; 9(1):308.

PMID: 39500878 PMC: 11539257. DOI: 10.1038/s41392-024-02004-x.


The Raf/LIN-45 C-terminal distal tail segment negatively regulates signaling in Caenorhabditis elegans.

Townley R, Stacy K, Cheraghi F, de la Cova C Genetics. 2024; 228(3).

PMID: 39288021 PMC: 11538406. DOI: 10.1093/genetics/iyae152.


Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damage.

Zerbib J, Ippolito M, Eliezer Y, De Feudis G, Reuveni E, Savir Kadmon A Nat Commun. 2024; 15(1):7772.

PMID: 39251587 PMC: 11385192. DOI: 10.1038/s41467-024-52176-x.


References
1.
Huser M, Luckett J, Chiloeches A, Mercer K, Iwobi M, Giblett S . MEK kinase activity is not necessary for Raf-1 function. EMBO J. 2001; 20(8):1940-51. PMC: 125235. DOI: 10.1093/emboj/20.8.1940. View

2.
Abraham D, Podar K, Pacher M, Kubicek M, Welzel N, Hemmings B . Raf-1-associated protein phosphatase 2A as a positive regulator of kinase activation. J Biol Chem. 2000; 275(29):22300-4. DOI: 10.1074/jbc.M003259200. View

3.
Weber C, Slupsky J, Kalmes H, Rapp U . Active Ras induces heterodimerization of cRaf and BRaf. Cancer Res. 2001; 61(9):3595-8. View

4.
Kao S, Jaiswal R, Kolch W, Landreth G . Identification of the mechanisms regulating the differential activation of the mapk cascade by epidermal growth factor and nerve growth factor in PC12 cells. J Biol Chem. 2001; 276(21):18169-77. DOI: 10.1074/jbc.M008870200. View

5.
Chong H, Lee J, Guan K . Positive and negative regulation of Raf kinase activity and function by phosphorylation. EMBO J. 2001; 20(14):3716-27. PMC: 125532. DOI: 10.1093/emboj/20.14.3716. View